文献速递静脉血栓栓塞慢性静脉疾病

下腔静脉血栓形成的表现与管理:单中心3年经验

Presentation and Management of Inferior Vena Cava Thrombosis.
PubMed 文献 · Ann Vasc Surg · 2018-10-27

单中心3年回顾性研究纳入41例影像确诊的下腔静脉血栓形成(IVCT)患者,43.9%为下腔静脉滤器血栓形成。26.8%患者出现肺栓塞(PE),滤器血栓形成组与de novo组PE风险无显著差异。65.9%仅用抗凝治疗,34.1%接受血管内干预,其中85.7%恢复下腔静脉通畅。

要点

  • IVCT患者中PE发生率约25%,滤器存在未降低PE风险。
  • 多数IVCT可单用抗凝管理,血管内干预可安全恢复通畅。
  • IVC滤器血栓形成是IVCT常见原因,占43.9%。

核心结论

  • IVCT罕见,与静脉血栓栓塞已知危险因素相关。
  • 发生IVCT时,滤器存在未显示预防PE的优势。
  • 多数IVCT单用抗凝管理,血管内干预可安全恢复多数合适患者的下腔静脉通畅。

研究设计与样本

  • 单中心回顾性研究,经IRB批准,使用ICD代码453.2筛选3年内影像确诊的IVCT患者。
  • 共纳入41例患者,平均年龄61岁(范围25-91),女性21例(51.2%)。
  • 按病因分为滤器血栓形成组(18例,43.9%)和de novo组。

主要发现

  • 滤器血栓形成组与de novo组PE风险无显著差异(38.9% vs. 17.4%,P=0.12)。
  • 14例(34.1%)接受干预,12例(85.7%)恢复下腔静脉通畅。
  • 治疗方式:单用抗凝27例(65.9%),CDT 5例(12.2%),机械血栓清除10例(24.4%),辅助IVC支架3例(7.3%)。

临床怎么用

  • IVCT患者应评估VTE危险因素,警惕PE发生。
  • 多数患者可单用抗凝治疗, selected患者可考虑血管内干预恢复通畅。
  • 滤器存在不排除IVCT后PE风险,需个体化评估。

局限性

  • 单中心回顾性设计,样本量小(41例)。
  • 干预组样本量有限(14例),技术成功定义仅为恢复通畅。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inferior vena cava thrombosis (IVCT), although rare, has a potential for significant morbidity and mortality. IVCT is often a result of IVC filter thrombosis, but it can also occur de novo. Although anticoagulation remains the standard of care, endovascular techniques to restore IVC patency have become key adjunctive therapies in recent years. This study examines a single-center experience with diagnosis and management of IVCT. METHODS: A retrospective Institutional Review Board-approved review of a single-center institutional database was screened to identify IVCT thrombosis using International Classification of Diseases code 453.2 over a 3-year period. Etiology of IVCT was separated into 2 groups: those with IVC thrombosis in the setting of prior IVC filter place and those in whom IVCT occurred de novo. Patient demographics, presenting characteristics, and management of IVCT were examined. Treatment options included expectant management with anticoagulation versus catheter-directed thrombolysis (CDT), mechanical thrombectomy, stenting, or a combination. For those who underwent intervention, technical success, defined as restoration of IVC patency, was assessed. RESULTS: Forty-one unique patients were identified with radiographically confirmed diagnosis of ICVT (mean age 61, range 25-91; 21 female, 51.2%). Eighteen (43.9%) patients presented with thrombosed IVC filter. Risk factors for venous thromboembolism included tobacco usage, current or prior smoking (n = 17, 41.5%), history of prior deep vein thrombosis (n = 25, 61.0%), malignancy (n = 17, 41.5%), use of hormonal supplements (n = 3, 7.3%), known thrombophilia (n = 4, 9.8%), and obesity (body mass index: mean 29, range 18.8-58.53). Eleven patients (26.8%) presented with pulmonary embolism (PE), and of those 63.6% had IVC filter thrombosis (n = 7). Risk of PE was not significantly different between those patients presenting with a thrombosed IVC filter compared to those with de novo IVCT (38.9% vs. 17.4%, P = 0.12) Management of IVCT included anticoagulation alone (n = 27, 65.9%), CDT (n = 5, 12.2%), mechanical thrombolysis (n = 10, 24.4%), and adjunctive IVC stent (n = 3, 7.3%). Among the 14 (34.1%) patients who had intervention for IVCT, patency was restored in 12 patients (85.7%). CONCLUSIONS: IVCT is a rare event and is associated with known risk factors for venous thromboembolism. PE can occur in roughly 25% of patients presenting with IVCT. Presence of a filter does not appear to confer an advantage in preventing PE when IVCT occurs. Although majority of IVCT is managed with anticoagulation alone, endovascular interventions, including lysis and stenting, can safely restore patency in most properly selected patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Teter K, Schrem E, Ranganath N, et al. Presentation and Management of Inferior Vena Cava Thrombosis. Ann Vasc Surg. 2018. PMID: 30982504. doi:10.1016/j.avsg.2018.08.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。